Hyam Levitsky
2015
In 2015, Hyam Levitsky earned a total compensation of $14.1M as Executive Vice President, Research and Chief Scientific Officer at Juno Therapeutics.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Non-Equity Incentive Plan | $93,333 |
| Option Awards | $5,930,750 |
| Salary | $237,949 |
| Stock Awards | $7,337,000 |
| Other | $43,460 |
| Total | $14,142,492 |
Levitsky received $7.3M in stock awards, accounting for 52% of the total pay in 2015.
Levitsky also received $500K in bonus, $93.3K in non-equity incentive plan, $5.9M in option awards, $237.9K in salary and $43.5K in other compensation.
Rankings
In 2015, Hyam Levitsky's compensation ranked 265th out of 13,638 executives tracked by ExecPay. In other words, Levitsky earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 265 out of 13,638 | 98th |
Division Manufacturing | 95 out of 5,187 | 98th |
Major group Chemicals And Allied Products | 40 out of 1,857 | 98th |
Industry group Drugs | 34 out of 1,531 | 98th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 260 | 98th |
Source: SEC filing on April 21, 2017.
Levitsky's colleagues
We found four more compensation records of executives who worked with Hyam Levitsky at Juno Therapeutics in 2015.